Labor Department Aims To Do Away With Over 60 Workplace Regulations
These regulations — such as minimum wage requirements, limiting exposure to harmful substances, and lighting at construction sites and mines — will impact workplace safety.
The independent source for health policy research, polling, and news.
2,441-2,460 of 112,980 results
These regulations — such as minimum wage requirements, limiting exposure to harmful substances, and lighting at construction sites and mines — will impact workplace safety.
Today's early morning highlights from the major news organizations.
Sarepta's pause on its prescription gene therapy drug for Duchenne muscular dystrophy gives the company time to work with the FDA on reviews. Infusions nationwide will be canceled. Also in the news, AstraZeneca, Sanofi, Humana, UnitedHealth, and more.
Experts hope the research, published Monday in the journal Nature Medicine, may allow for earlier interventions. Other research-related news is on the first pill for postpartum depression, antibiotic prescribing at urgent care clinics, an experimental mRNA vaccine targeting cancer, and more.
Remote work made necessary by the pandemic exposed employee burnout and disconnection. Researchers found a four-day workweek improved these issues. In other news: Covid cases are climbing across the U.S.; Measles exposure in day cares has ripple effects; and more.
Editorial writers tackle these public health issues.
As the Supplemental Nutrition Assistance Program, or SNAP, readies for the biggest budget cuts in its history, nonprofit food banks strain to fight food insecurity. Other states making news: Mississippi, Texas, Connecticut, North Carolina, California, Colorado, Missouri, and Maine.
A House subcommittee will hold a hearing today covering safety lapses and improvements to be made to the organ donor system. In other news: the FDA's debate on antidepressant use during pregnancy; the impact of NIH cuts on science; and more.
By 2034, more than 10 million people will be uninsured under President Donald Trump’s tax and spending law, the Congressional Budget Office finds in a revised analysis of the bill. That's an improvement from an earlier projection that found 11.8 million people would lose coverage in that time period.
Today's early morning highlights from the major news organizations.
“We can’t survive this big a cut," said public health department chief Barbara Ferrer. Other states making news: Georgia, Illinois, Maryland, Louisiana, Maine, North Carolina, and Ohio.
Reducing redundancy and improving hospital compliance are among the goals. Other industry news is on health system purchases of physician practices, insurance claim denials, and more.
Among the factors are cataracts, glaucoma, age-related macular degeneration, nearsightedness, and farsightedness. An estimated 5% to 19% of U.S. dementia cases were attributable to vision impairment, a recent study showed. Other news is on chronic Lyme disease acceptance, computer prompts to help stave off antibiotic over prescription, and more.
The increased use of a type of organ removal called donation after circulatory death has led to a rise in disturbing transplant stories. This method allows doctors to make a judgment call that patients, although alive and still with brain activity, are near enough to death and won’t recover.
An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the analysis suggests. Plus, the Trump administration rejects WHO health regulation changes.
Opinion writers discuss these public health issues.
The Trump administration plans to use Title X funds previously allocated for providing birth control to low-income patients to instead teach women about alternative approaches to infertility.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on federal funding and workforce cuts, ACIP, weight loss drugs, birthing alternatives, and more.
Opinion writers examine these public health topics.
© 2026 KFF